Works by Hyun Cheol Chung


Results: 186
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19

    Relationship between p53 Overexpression and Gastric Cancer Progression.

    Published in:
    Oncology, 1997, v. 54, n. 2, p. 166, doi. 10.1159/000227682
    By:
    • Kim, Joo-Hang;
    • Uhm, Hyo Dong;
    • Gong, Soo Jung;
    • Shin, Dong Hwan;
    • Choi, Jin Hyuk;
    • Lee, Hye Ran;
    • Noh, Sung Hoon;
    • Kim, Byung Soo;
    • Cho, Jae Yong;
    • Rha, Sun Young;
    • Yoo, Nae Choon;
    • Chung, Hyun Cheol;
    • Roh, Jae Kyung;
    • Min, Jin Sik;
    • Lee, Kyong Sik
    Publication type:
    Article
    20

    Overexpression of c-ErbB-2 Protein in Gastric Cancer by Immunohistochemical Stain.

    Published in:
    Oncology, 1996, v. 53, n. 3, p. 192, doi. 10.1159/000227559
    By:
    • Lee, Hye Ran;
    • Kim, Joo-Hang;
    • Uhm, Hyo Dong;
    • Ahn, Joong Bae;
    • Rha, Sun Young;
    • Cho, Jae Yong;
    • Lee, Jong In;
    • Lee, Kyong Hee;
    • Chung, Hyun Cheol;
    • Roh, Jae Kyong;
    • Min, Jin Sik;
    • Lee, Kyong Sik;
    • Shin, Dong Hwan;
    • Kim, Byung Soo;
    • Hong, Soon Won;
    • Choi, Jin-Hyuk
    Publication type:
    Article
    21
    22
    23
    24

    A Phase II Trial of S-1 and Oxaliplatin in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane (KCSG-BR07-03).

    Published in:
    Cancer Research & Treatment, 2023, v. 55, n. 2, p. 523, doi. 10.4143/crt.2022.1360
    By:
    • Dae-Won Lee;
    • Bhumsuk Keam;
    • Keun Seok Lee;
    • Jin-Hee Ahn;
    • Joohyuk Sohn;
    • Jin Seok Ahn;
    • Moon Hee Lee;
    • Jee Hyun Kim;
    • Kyung Eun Lee;
    • Hyo Jung Kim;
    • Si-Young Kim;
    • Yeon Hee Park;
    • Chan-Young Ock;
    • Kyung-Hun Lee;
    • Sae-Won Han;
    • Sung-Bae Kim;
    • Young Hyuck Im;
    • Hyun Cheol Chung;
    • Do-Youn Oh;
    • Seock-Ah Im
    Publication type:
    Article
    25
    26
    27
    28
    29
    30
    31
    32
    33

    Pembrolizumab or pembrolizumab plus chemotherapy versus standard of care chemotherapy in patients with advanced gastric or gastroesophageal junction adenocarcinoma: Asian subgroup analysis of KEYNOTE-062.

    Published in:
    Japanese Journal of Clinical Oncology, 2023, v. 53, n. 3, p. 221, doi. 10.1093/jjco/hyac188
    By:
    • Satake, Hironaga;
    • Lee, Keun-Wook;
    • Chung, Hyun Cheol;
    • Lee, Jeeyun;
    • Yamaguchi, Kensei;
    • Chen, Jen-Shi;
    • Yoshikawa, Takaki;
    • Amagai, Kenji;
    • Yeh, Kun-Huei;
    • Goto, Masahiro;
    • Chao, Yee;
    • Lam, Ka-On;
    • Han, Shi Rong;
    • Shiratori, Shinichi;
    • Shah, Sukrut;
    • Shitara, Kohei
    Publication type:
    Article
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43

    Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: pooled analyses after long-term follow-up in KEYNOTE-012.

    Published in:
    2018
    By:
    • Mehra, Ranee;
    • Seiwert, Tanguy Y.;
    • Gupta, Shilpa;
    • Weiss, Jared;
    • Gluck, Iris;
    • Eder, Joseph P.;
    • Burtness, Barbara;
    • Tahara, Makoto;
    • Keam, Bhumsuk;
    • Kang, Hyunseok;
    • Muro, Kei;
    • Geva, Ravit;
    • Chung, Hyun Cheol;
    • Lin, Chia-Chi;
    • Aurora-Garg, Deepti;
    • Ray, Archana;
    • Pathiraja, Kumudu;
    • Cheng, Jonathan;
    • Chow, Laura Q. M.;
    • Haddad, Robert
    Publication type:
    journal article
    44

    Alpha-fetoprotein kinetics in patients with hepatocellular carcinoma receiving ramucirumab or placebo: an analysis of the phase 3 REACH study.

    Published in:
    2018
    By:
    • Chau, Ian;
    • Park, Joon Oh;
    • Ryoo, Baek-Yeol;
    • Yen, Chia-Jui;
    • Poon, Ronnie;
    • Pastorelli, Davide;
    • Blanc, Jean-Frédéric;
    • Kudo, Masatoshi;
    • Pfiffer, Tulio;
    • Hatano, Etsuro;
    • Chung, Hyun Cheol;
    • Kopeckova, Katerina;
    • Phelip, Jean-Marc;
    • Brandi, Giovanni;
    • Ohkawa, Shinichi;
    • Li, Chung-Pin;
    • Okusaka, Takuji;
    • Hsu, Yanzhi;
    • Abada, Paolo B.;
    • Zhu, Andrew X.
    Publication type:
    journal article
    45
    46
    47

    A Phase Ib pharmacokinetic study of the anti-angiogenic agent CKD-732 used in combination with capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer patients who progressed on irinotecan-based chemotherapy.

    Published in:
    Investigational New Drugs, 2012, v. 30, n. 2, p. 672, doi. 10.1007/s10637-010-9625-x
    By:
    • Shin, Sang Joon;
    • Ahn, Joong Bae;
    • Park, Kyung Soo;
    • Lee, Yoon Jung;
    • Hong, Yong Sang;
    • Kim, Tae Won;
    • Kim, Hye Ryun;
    • Rha, Sun Young;
    • Roh, Jae Kyung;
    • Kim, Dal-Hyun;
    • Kim, Chin;
    • Chung, Hyun Cheol
    Publication type:
    Article
    48
    49
    50